History

Coats disease is an idiopathic condition characterized by telangiectatic and aneurysmal retinal vessels with intraretinal and subretinal exudation and fluid.¹ Coats disease was first described by Scottish ophthalmologist George Coats in 1908.² In his initial classification, Coats separated this new entity into three distinct groups. Group I included eyes with massive subretinal exudation and no demonstrable vascular abnormalities. Group II consisted of eyes with massive subretinal exudation and multiple retinal vascular abnormalities with intraretinal hemorrhage. Group III included eyes with massive subretinal exudation and frank retinal arteriovenous malformations.² Eugen von Hippel later demonstrated that group III represented the distinctly separate entity of angiomatosis retinae (later retermed retinal capillary hemangioma or retinal hemangioblastoma), prompting Coats to drop this group from his classification. In 1912, and again in 1915, Theodor von Leber described a disease with similar telangiectatic and aneurysmal retinal vessels that lacked the massive subretinal exudation described by Coats.^3,4 This condition was later named Leber multiple miliary aneurysms. In a 1916 paper, Leber concluded that what he had described was merely an earlier stage of the disease process identified by Coats.^5,6 This conclusion was later reinforced by Reese, who described an eye with Leber miliary aneurysms that progressed into a classic case of Coats disease during long-term follow-up.⁷ Although some authors have disagreed, most authorities today classify Leber disease as an early or nonprogressive form of Coats disease.^5,8,9

Histopathology, etiology, and pathogenesis

Early descriptions of Coats disease focused primarily on the morphology of the disease and attempted to explain the disease process solely on the basis of fundoscopic and histopathologic changes.^10,11 The first observations published by Coats focused on histopathologic examination of six eyes enucleated for this condition that he received from various colleagues.² From these histopathologic specimens, Coats described subretinal masses of fibrous tissue intimately adherent to the outer retina. Most of the eyes had associated retinal thickening, degeneration, and detachment, as well as diffuse vascular abnormalities. Four of the six eyes had associated retinal hemorrhages and most had cholesterol crystals. One eye had evidence of bone formation. Coats believed the vascular changes represented secondary manifestations of the underlying disease and that the exudation was secondary to organization and partial resorption of retinal hemorrhages, as he often found hemorrhages in association with the exudation.² Coats also postulated that the primary process might be infectious in light of the mononuclear infiltrate found on histopathologic examination. This infectious theory of Coats disease was supported by a number of other reports, including that of Evens,¹² Straub,¹³ and Müller,¹³ who suspected toxoplasmosis as the underlying cause. Subsequent investigations and the failure of anti-inflammatory adrenocorticotropic hormone and steroid therapies have refuted early theories of a primary infectious or inflammatory etiology.^13,14

Pathologic samples of eyes with Coats disease were once abundant owing to enucleations for suspected intraocular tumor.¹⁵ Moreover, most histopathologic reports describe findings in eyes with advanced stages of the disease. Gross examination of enucleated eyes typically reveals bullous retinal detachment.¹⁶ Subretinal fluid has a viscous, lipid-rich, yellow appearance with glistening crystals.¹⁶ Microscopically, the subretinal exudation contains collections of foamy histiocytes and cholesterol clefts.¹⁶ The outer retina is thickened by exudation, with variable penetration of inner retinal layers.¹⁶ Areas of the inner retina also contain numerous, large, dilated, and telangiectatic vessels.¹⁶ Other vascular abnormalities include degenerated and hypocellular walls, narrowed lumen with or without thrombi, capillary dropout, neovascularization, as well as perivascular sheathing and/or pigmentation.^1,9,17–23 Thickened vessel walls show characteristic heavy periodic acid–Schiff-positive deposits.¹ Flat preparations prepared by trypsin digestion reveal vascular aneurysms measuring 50–350 µm, often forming large sausage-like outpouchings and located on shunt vessels.¹ Advanced cases may have intraocular bone formation, with evidence of calcification on echography and computed tomography (CT) scanning that potentially confuses the diagnosis with retinoblastoma.^24,25 Electron microscopy confirms diffuse structural abnormalities of the retinal vasculature. Tripathi and Ashton described prominent structural alterations of retinal vessels in areas of retinal thickening, with thickened walls mostly replaced by a laminated fibrous coating of basement membrane-like material.¹⁸ Most affected vessels were completely devoid of endothelium and pericytes, with red blood cells, plasma, and fibrin filling the lumina. There was patchy thinning or even absence of the vessel wall in some areas, with the vessel lumen extending to the basement membrane of adjacent glial cells.¹⁸ These findings support the widely held view that Coats disease is a disorder of vascular integrity.

Indeed, recent work in molecular genetics suggests that Coats disease may be part of a spectrum of related genetic disorders known as “retinal hypovasculopathies”^26,27 which includes Norrie disease, familial exudative vitreoretinopathy (FEVR), fascioscapulohumeral muscular dystrophy (FSHD), and the osteoporosis pseudoglioma syndrome.^27–35 These diseases share a similar ocular phenotype, characterized by a failure to vascularize fully the retinal periphery and associated telangiectatic, incompetent remnant vasculature. Each of these conditions can be related to abnormalities in the Wnt signalling pathway during retinal angiogenesis.^26,27,36

Several reports have implicated a deficiency of Norrin, a retinal protein, in the pathogenesis of Coats disease.^37,38 In one case report, a female with unilateral Coats disease gave birth to a son affected by Norrie disease.³⁷ Both carried a missense mutation within the Norrie disease pseudoglioma (NDP) gene on chromosome Xp11.2. Further analysis on archival tissue from nine enucleated eyes from males with unilateral Coats disease revealed a mutation in the NDP gene in one subject. Knockout mouse models of Norrie disease model demonstrate abnormalities of the retinal vessels, including telangiectasia, bulb-like dilatations, and underdevelopment of the capillary bed.^39,40 Elevated levels of hypoxia-inducible factor-1α and vascular endothelial growth factor (VEGF), as well as characteristic electroretinogram patterns in these mice, confirmed inner retinal hypoxia.⁴⁰ Moreover, ectopic lens expression of Norrin in knockout mice induces the formation of normal deep retinal capillaries, and completely prevents abnormalities in retinal angiogenesis.⁴¹ These observations suggest a genetic basis for Coats disease and that a mutation in the NDP gene may be responsible.

Although FEVR and Coats disease share certain clinical features, they likely do not share a common genetic basis. Robataille and associates studied DNA expression of Frizzled-4 (FZD4) in 68 cases of FEVR and 16 cases of Coats disease.⁴² They found 11 FZD4 mutations in FEVR cases and no mutations in Coats disease cases. They concluded that germline mutations in FZD4 do not appear to be a common cause of Coats disease, implying that Coats disease does not likely represent asymmetric FEVR and is a distinct ocular condition.

Other genetic pathways have been explored. Cremers and associates found that 55% of eyes with retinitis pigmentosa and Coats-like secondary exudative vasculopathy contained a mutation in the CRB1 gene.⁴³ This suggests that the CRB1 gene could be involved in primary Coats disease as well as other retinal diseases and dystrophies.

Clinical presentation

Coats disease is classically a painless ophthalmic condition. The disease affects males three times as often as females and has no reported racial or ethnic predilection.⁴⁴ Coats disease is unilateral in 80–95% of cases.^5,44,45 Some of the bilateral cases in older reports could represent secondary bilateral Coats-like retinopathy with systemic conditions and not true primary Coats disease. Any patient with bilateral presumed Coats disease should be evaluated for conditions that causes Coats-like exudative retinopathy such as retinitis pigmentosa, pars planitis, FSHD, FEVR, or other diseases.⁴⁶ Based on a study of 150 consecutive cases, the mean age at diagnosis is 5 years with a range of 1 month to 63 years.⁴⁴ Some speculate that the disease could be present at birth.^13,47

In an analysis of 150 consecutive cases of Coats disease, presenting symptoms included decreased visual acuity (43%), strabismus (23%: Fig. 56.1), leukocoria/xanthocoria (20%: Fig. 56.1), pain (3%), heterochromia (1%), nystagmus (1%), and no symptom (8%).⁴⁴ Visual acuity was 20/20 to 20/50 in 12% of all eyes, 20/60 to 20/100 in 11%, 20/200 to counting fingers in 18%, and hand motions to no light perception in 58%. Nearly 90% of eyes had a normal anterior-segment examination. Those with findings included cataract (8%), iris neovascularization (8%), shallow anterior chamber (4%), corneal edema (3%), cholesterol in the anterior chamber (3%: Fig. 56.1),^48,49 and megalocornea (2%). Retinal findings included telangiectasia (100%), intraretinal exudation (99%), exudative retinal detachment (81% with 42% demonstrating partial retinal detachment and 58% with total retinal detachment), retinal hemorrhage (13%), retinal macrocyst (11%), vasoproliferative tumor (6%), and optic disc neovascularization (1%). No eyes in this cohort presented with vitreous hemorrhage. Other studies have described macular fibrosis in up to 23% of patients, developing in an area of previous dense exudation, and involving the fovea in all cases.⁵⁰

Fig. 56.1 Unique clinical features occasionally seen in Coats disease. (A) Young boy who presented with leukocoria and esotropia of the left eye. He had stage 5 disease, including total retinal detachment, cataract, and prephthisis. The decision was made to observe. (B) Young girl with xanthocoria of the right eye. (C) Young girl who presented with a total retinal detachment abutting the posterior surface of the lens. (D) Young girl with anterior-chamber cholesterolosis of the right eye.

Adult cases of Coats disease are similar in clinical presentation and disease course, but generally have a smaller area of involvement, slower disease progression, more frequent hemorrhage near larger aneurysmal dilated vessels, and typically do not present with strabismus.⁵¹ Although the adult form of the disease has been described as frequently associated with hypercholesterolemia, such an association does not appear to occur in the juvenile form.^14,52

The typical ophthalmoscopic picture in Coats disease is that of localized, yellow, subretinal exudation associated with adjacent vascular anomalies, including sheathing, telangiectasia, tortuosity, aneurysmal dilation, zones of capillary dropout, and occasionally neovascularization.^13,44 There is variability in this clinical picture.⁴⁴ Exudation, hemorrhage, or a combination appears minimal during less active stages of the disease and can progress to massive findings, obscuring the retinal vasculature in more aggressive stages. The vascular abnormalities can be subtle and clinically undetectable or can be obvious as a dominant feature. The clinical course is also variable, but is generally slowly progressive. Spontaneous remission has been observed but is exceptional.⁵³ Subretinal choroidal neovascularization rarely occurs in areas of lipid deposition. As subretinal fluid and exudation increase, the retinal detachment progresses and can reach a highly elevated state, visible behind the lens (Fig. 56.1). Hemorrhagic and nonhemorrhagic retinal macrocysts can occur as a result of chronic coalescent intraretinal cystoid edema.⁵⁴ Secondary complications such as iridocyclitis, cataract, and secondary neovascular glaucoma can lead to phthisis bulbi in severe cases.^2,15,55

Several staging systems for Coats disease have been proposed.^2,56 The most recent and widely used was introduced by Shields and associates in 2000 (Table 56.1).⁵⁷ Stage 1 is characterized by retinal telangiectasia. Stage 2 has telangiectasia and intraretinal exudation, extrafoveal exudation defines stage 2A (Fig. 56.2), whereas foveal involvement defines stage 2B. Stage 3 is defined by exudative retinal detachment, 3A is a subtotal detachment, with 1 and 2 designating extrafoveal and foveal involvement, respectively (Fig. 56.3), and 3B is a total retinal detachment (Fig. 56.4). Stage 4 has total retinal detachment plus elevated intraocular pressure (Fig. 56.3), and stage 5 is endstage disease, occasionally with phthisis bulbi (Fig. 56.1). Using this classification for grouping of 124 cases, Shields and associates found stage 1 in 1%, stage 2 in 14% (2A in 8%, 2B in 6%), stage 3 in 69% (3A1 in 19%, 3A2 in 19%, 3B in 30%), stage 4 in 15%, and stage 5 in 2%.⁵⁷ Based on classification and treatment, visual acuity strongly depended on stage at diagnosis.^44,58 At the time of Coats disease control, poor visual acuity (20/200 or worse) was found in 0% of stage 1, 53% of stage 2, 74% of stage 3, and 100% of stage 4 and stage 5.⁵⁷

Fig. 56.2 Clinical imaging of a 10-year old Latina girl with stage 2A Coats disease in the left eye. (A) Montage color photograph. Note the exudation and vascular telangiectasia in the far temporal periphery. (B) Midphase wide-field fluorescein angiogram of the same patient. Note the far peripheral avascularity and adjacent telangiectatic vasculature. (C) Late-phase wide-field fluorescein angiogram of the same patient. Note the mild dye leakage from telangiectasia.

Fig. 56.3 Clinical images of various stages of Coats disease, including 3A1, 3A2, and 4. (A) Color fundus photograph of a patient with stage 3A1 Coats disease. Note the temporal extrafoveal exudation. (B) Recirculation-phase fluorescein angiogram of the same patient as in (A). Note the temporal vascular abnormalities, areas of capillary nonperfusion, and perivascular dye leakage. (C) Color fundus photograph of a patient with stage 3A2 Coats disease with prominent foveal exudation. Also note the subtle temporal vascular telangiectasia and aneurysmal vessels. (D) The extent of vascular abnormalities is more apparent in this midphase fluorescein angiogram. Note the telangiectasia adjacent to a wide zone of peripheral avascularity. (E) Color fundus photograph of a patient with stage 4 disease who presented with a total exudative retinal detachment and elevated intraocular pressure. (F) Fluorescein angiography revealed prominent capillary nonperfusion between dilated, abnormal vasculature.

Fig. 56.4 Clinical imaging of a 17-year-old African American man with stage 3B Coats disease in the right eye. (A) Montage color fundus photograph depicting extensive subretinal exudation, a total retinal detachment, diffuse midperipheral vascular abnormalities, and optic nerve head neovascularization. (B) Early-phase fluorescein angiogram, centered more temporally than the color photo, demonstrating filling of telangiectatic and aneurysmal vascular channels, most prominent in the temporal periphery. Adjacent to telangiectatic vessels are large areas of retinal capillary nonperfusion. (C) In the later phase of the angiogram, leakage of dye from telangiectatic vessels and disc neovascularization are seen.

(Courtesy of Carl Regillo, MD, Wills Eye Institute.)

Diagnostic testing

Ancillary testing may be useful when the diagnosis of Coats disease is suspected, but other clinical entities must be ruled out, most notably retinoblastoma.⁵⁹ Particularly when retinal detachment with subretinal exudation and dilated retinal vessels coexist, even an experienced clinician may have difficulty differentiating these entities ophthalmoscopically. Fluorescein angiography is critical to document classic findings to establish the diagnosis. Echography may enable differentiation between Coats disease and retinoblastoma on the basis of features such as the character of the retinal detachment and the presence or absence of subretinal calcifications. Echography is less useful when the retinoblastoma is poorly calcified and also has shortcomings in detecting optic nerve or extraocular extension of retinoblastoma when heavy calcification exists.⁶⁰

Fluorescein angiography

The typical fluorescein angiographic picture of Coats disease is one of numerous localized anomalies of the retinal vasculature with peripheral retinal nonperfusion (Figs 56.2–56.6). Telangiectasia, aneurysms, beading of vessel walls, and various vascular communicating channels are found with larger vessels. These vessels show early and persistent leakage, which verifies their role as the source of exudation and hemorrhage. This leakage represents breakdown of the blood–retinal barrier, which can further be detected by vitreous fluorophotometry.⁶¹ Microvascular involvement is demonstrated with areas of diffuse loss of the capillary bed or areas of complete capillary nonperfusion on angiography. Geographic zones of microvascular involvement are typically surrounded by areas of arteriolar and venular anomalies. Although some early authors described cases of massive exudation or hemorrhage without areas of obvious vascular involvement, fluorescein angiography and histopathologic specimens invariably show unsuspected anomalous vessels. The ability to identify all anomalous vessels, especially those with the greatest degree of leakage, has made adequate treatment of Coats disease a possibility.^5,57,62,63

Fig. 56.5 Color fundus photography and fluorescein angiography of a patient with stage 4 Coats disease. Macular (A) and inferior (B) color photographs depicting extensive subretinal exudate. Note the elevated retinal detachment in B. (C) Early-phase fluorescein angiogram of the superonasal retinal periphery. Note the blunted, telangiectatic, and aneurysmal vasculature just posterior to a zone of avascular retina. (D) Midphase fluorescein angiogram of the inferior retina corresponding to (B), depicting similar angiographic findings as well as prominent sausage-like vascular dilations.

Fig. 56.6 Color fundus photography and fluorescein angiogram of a patient with a total bullous retinal detachment associated with Coats disease. (A) Color fundus photograph depicting the very bullous retinal detachment. (B–D) Fluorescein angiogram images of the same patient depicting typical angiographic features of Coats disease.

Differential diagnosis

The differential diagnosis of Coats disease includes other conditions that produce leukocoria or strabismus,¹⁹ including retinoblastoma,^15,69 retinal detachment, persistent hyperplastic primary vitreous, congenital cataract, Norrie disease, and FEVR,⁷⁰ among other diagnoses. Shields and associates reviewed 150 cases of Coats disease and found that the diagnosis was correct in 64 cases (41%).⁴⁴ The mistaken referring diagnoses included retinoblastoma in 43 cases (27%), retinal detachment in 12 (8%), retinal hemorrhage in 7 (4%), toxocariasis in 4 (3%), choroidal melanoma in 2 (1%), choroidal hemangioma in 2 (1%), coloboma in 2 (1%), endophthalmitis in 2 (1%), and single cases of cytomegalovirus retinitis, retinopathy of prematurity, traumatic retinopathy, and toxoplasmosis. In 18 cases (11%) there was no submitted diagnosis.

Numerous entities have been described as presenting with a Coats-like picture, including several systemic conditions, and Coats disease can also simulate other exudative retinal conditions such as FEVR, peripheral vasculitis, Eales disease, and FSHD (Table 56.2). FEVR is an important consideration and can present with peripheral avascularity with telangiectasia and exudation. FEVR can be differentiated based on the typical presence of retinal dragging, a positive family history, and bilaterality, all of which are rare in Coats disease. A Coats-like picture of bilateral retinal telangiectasia and exudation has been described in patients with deafness and FSHD.^71–73 It is believed that the retinal vascular abnormalities, muscular dystrophy, and deafness in FSHD may all be a consequence of a common mechanism based on abnormal Wnt signaling.³⁵

Table 56.2 Clinical conditions that can present with Coats-like retinal findings

A Coats-like picture associated with varied skeletal defects, cerebellar and extrapyramidal movement disorder, epileptic seizures, leukodystrophic changes, and postnatal growth failure has been referred to as “Coats plus syndrome.”⁷⁴ In order to avoid confusion, the term “Coats disease” should be reserved for cases of idiopathic retinal telangiectasia associated with intraretinal exudation with or without exudative retinal detachment, without evidence of vitreoretinal traction.^7,44

Isolated case reports have described a number of other disorders occurring concurrently with Coats disease, including retinitis pigmentosa,^75,76 Senior–Loken syndrome,⁷⁷ the ichthyosis hystrix variant of epidermal nevus syndrome,⁷⁸ Turner’s syndrome,⁷⁹ diffuse central nervous system venous abnormality,⁸⁰ and Hallermann–Streiff syndrome⁸¹ (Table 56.2). Small, in 1968, reported the combination of mental retardation, muscular dystrophy, and an exudative vasculopathy in four siblings.⁷¹ Egerer and associates noted histologic evidence of rosettes characteristic of retinal dysplasia in a series of nine enucleated eyes carrying the diagnosis of Coats disease.⁸² Fogle and colleagues noted an exudative vasculopathy with a clinical picture similar to that of Coats disease arising from abnormal choroidal vessels in both eyes of a patient with retinitis pigmentosa.⁸³ Despite these reports, no definite connection has been made between other systemic or ocular conditions and Coats disease.

Treatment

Treatment for Coats disease depends on the stage of disease. Mild cases with only retinal telangiectasia (stage 1) should be documented with color fundus photography and wide-field fluorescein angiography and followed conservatively. If subretinal fluid or exudation develop, then intervention is necessary. For more advanced stages (2 through 4), treatment involves ablation with photocoagulation or cryotherapy to areas of telangiectatic vasculature and retinal nonperfusion. Surgical intervention to repair traction, hemorrhage, or rhegmatogenous retinal detachment is rarely necessary.

Ablative therapies – laser photocoagulation and cryotherapy

In less severe cases of exudation due to Coats disease, with or without retinal detachment, argon or diode laser photocoagulation is the treatment of choice (Fig. 56.7).^84–86 Fluorescein angiographic guidance assists directed treatment of vascular leakage. Most wavelengths of laser light are adequate for treatment, although those near the yellow portion of the spectrum have better absorption by blood in the target vascular channels and may be particularly useful if the vessels are in detached retina. Leaking lesions are treated directly with moderate to large (100–500 µm, depending on size and location of the target lesions) applications of moderate-intensity light. Scatter photocoagulation to areas of extensive nonperfusion is of unproven value but could decrease the risk of later neovascularization. If lesions are too peripheral to be reached with the slit-lamp delivery system, the indirect ophthalmoscope-mounted laser, transscleral laser, or cryotherapy can be used.⁸⁷ These methods may be particularly useful in small children, who usually require general anesthesia for treatment. Of note, extensive laser photocoagulation can result in transient disruption of the blood–retinal barrier, paradoxically increasing retinal exudation. Several sessions of therapy, approximately every 3 months, are often necessary to produce complete resolution of exudation or detachment.^57,84,88 Complications of photocoagulation in Coats disease include inflammation, choroidal detachment, progressive exudation, creation of chorioretinal and vitreochoroidal anastomoses, epiretinal membrane formation, sympathetic ophthalmia, rhegmatogenous retinal detachment, and hemorrhage.

Fig. 56.7 Color fundus photographs from two patients demonstrating the effect of laser photocoagulation. Laser photocoagulation was used to treat focal areas of leakage in the peripheral retina with a modified scatter pattern to zones of capillary nonperfusion. Burns were 100–500 µm and of moderate intensity applied through a fundus contact lens. (A) Montage color fundus photograph of a separate patient with stage 4 Coats disease. Note the extensive exudation. (B–E) Sequential color fundus photographs following treatment with laser photocoagulation; the exudation and retinal detachment were noted to be slowly improving. (F) Color fundus photograph of the left macula in a patient with stage 3A1 Coats disease. (G) Fluorescein angiogram of the same patient delineating areas of retinal nonperfusion and vascular abnormalities that are used to guide laser photocoagulation. (H) Montage color photograph of the same patient following treatment with laser photocoagulation. Note the laser scars in the far temporal periphery as well as the total resolution of retinal exudation. The visual acuity following treatment improved to 20/20.

Double freeze–thaw cryotherapy is also useful in ablating affected areas of the retina, and is particularly helpful in cases where laser is ineffective, such as extensive subretinal exudation or retinal detachment. In some cases it may be necessary to drain subretinal fluid to obtain sufficient retinal vascular freezing. As with laser photocoagulation, many more advanced cases require multiple sessions.⁵⁷ To minimize side-effects in eyes with extensive vascular abnormalities, selective treatment with cryotherapy to two or fewer quadrants per session may be advised, as well as avoidance of the ciliary body. In some cases with advanced disease and imminent glaucoma, treatment of the entire four quadrants of the retina is necessary. Compared to laser, cryotherapy is associated with more inflammation and patient discomfort as well as potential complications, which include subcapsular cataract, proliferative vitreoretinopathy, and total retinal detachment.⁶³

The use of photodynamic therapy in combination with intravitreal bevacizumab for adult Coats disease was reported in a single case report, with apparent success.⁸⁹ Diathermy also can be used as an alternative to cryotherapy or laser.

Surgery

Less invasive measures are usually effective in treating exudative retinal detachment with Coats disease;¹⁰⁵ however eyes with advanced retinal detachment abutting the crystalline lens or those with a rhegmatogenous component to the detachment may benefit from surgical repair.

Machemer and Williams reported improvement in the clinical course of selected cases of Coats disease with vitreous surgery consisting of removal of vitreal and preretinal membranes to eliminate traction detachment, combined with destruction of leaking vessels.¹⁰⁶ Other authors have advocated the use of vitrectomy with internal drainage of subretinal fluid to flatten the retina, before vasoablative procedures, and intraocular tamponade with gas or silicone oil.^107–109 Silodor and associates have used intraocular infusion, drainage of subretinal fluid, and cryotherapy with success in eyes with advanced bullous retinal detachment.¹¹⁰ In their series of 13 children with blindness from Coats disease, six that were followed without surgery developed painful neovascular glaucoma necessitating enucleation and seven that were surgically repaired avoided glaucoma and the eyes remained cosmetically acceptable. When transscleral drainage of extensive subretinal fluid is necessary, a pediatric infusion cannula placed in the anterior chamber works well for maintaining the globe (Fig. 56.8).

Fig. 56.8 In this eye of an 18-month-old boy with total exudative retinal detachment, anatomic stability was achieved by infusion into the anterior chamber, posterior drainage of subretinal fluid, and cryotherapy to 11 clock-hours of peripheral vascular anomalies.

(Reproduced with permission from Haller JA. Coats’ disease and retinal telangiectasia. In: Yanoff M, Duker JS, editors. Ophthalmology. London: Mosby; 1999.)

Endstage cases associated with neovascular or angle closure glaucoma, or a blind painful eye may require enucleation.^57,111 Alternatively, eyes with neovascular glaucoma may respond to transscleral diode laser cyclophotocoagulation.¹¹²

Outcomes

In a series of 103 eyes, published by Shields and associates in 2001, telangiectasia resolved completely (47%) or partially (53%) over a mean interval of 15 months following treatment.⁵⁷ Following treatment, inactive telangiectasia and old exudation were found in 45% of cases at 17 months.⁵⁷ Residual telangiectatic areas are often left untreated, especially if there is no fresh exudation or subretinal fluid. The goal of treatment is to close telangiectasia so that further leakage is halted. In 7% of cases by 10 years, recurrence of leakage from residual or new telangiectasia can occur.⁵⁷

Anatomically, most cases (76%) stabilize or improve following treatment, with the minority (8%) progressively worsening.⁵⁷ Approximately 20% require enucleation for neovascular glaucoma or painful phthisis bulbi.⁵⁷ In the large series by Shields and colleagues on 150 patients, 117 individuals (124 eyes) were managed and followed for a median of 23 months and outcomes were determined. Management included observation in 22 eyes (18%), photocoagulation in 16 (13%), cryotherapy in 52 (42%), retinal detachment repair with drainage of subretinal fluid and cryotherapy or photocoagulation in 20 (17%), and enucleation in 14 (11%). Often multiple sessions were required. The median interval from initial treatment to complete resolution of telangiectasia was 10 months (range 2–123 months). Exudation resolved completely in 46 cases (45%) over a median of 12 months. Of the 88 eyes with retinal detachment prior to treatment, 50 (57%) had complete resolution of the detachment. Unfortunately, visual outcome with this condition is generally poor as foveal exudation and retinal detachment often destroy macular function. In that series, final visual acuity was 20/50 or better in 16%, 20/60 to 20/100 in 8%, 20/200 to finger counting in 29%, and hand motions to no light perception in 47%.⁵⁷ Severe vision loss was due to persistent foveal exudation, retinal detachment, and/or subfoveal fibrosis. Risk factors predictive of poor visual outcome (20/200 or worse) included noncaucasian race, postequatorial (P = 0.01), diffuse (P = 0.01), or superior (P = 0.04) location of telangiectasia and exudation, failed resolution of subretinal fluid after treatment (P = 0.02), and presence of retinal macrocysts (P = 0.02). Significant risk factors for enucleation included elevated intraocular pressure (greater than 22 mm Hg; P < 0.001) and iris neovascularization (P < 0.001) at presentation.

Following resolution of exudation, extensive subretinal fibrosis and pigmentation, particularly in the fovea, can limit visual recovery. Intraocular surgical intervention carries the added risks of endophthalmitis, retinal tear formation, rhegmatogenous retinal detachment, and proliferative vitreoretinopathy.^{5,79,113–116} Patients should be followed lifelong for recurrence (Fig. 56.9).^57,117–119

Fig. 56.9 This patient, previously treated successfully for Coats-type exudative retinopathy (see old scarring and fibrosis to the left of the photograph), has now developed a new adjacent area of vascular malformation and aneurysmal dilation, with a circinate lipid exudate.